MetLife (MET)
(Delayed Data from NYSE)
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Zacks News
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
A Look at Insurance ETFs Post a Mixed Bag Q1
by Sweta Killa
With the Fed slowing down the pace of rate hike and expectations of a pause in further hikes coupled with mixed results of the leading players in the industry, insurance ETFs struggled to find a footing over the last month.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Company News for May 5, 2023
by Zacks Equity Research
Companies in The News Are: MET, COP, XOM, WAL
MetLife (MET) Q1 Earnings Miss on Lower Investment Income
by Zacks Equity Research
MetLife's (MET) reduced profit levels from Asia and MetLife Holdings businesses affect its first-quarter performance.
MetLife (MET) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -17.84% and 4.09%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Insurance Stocks to Post Q1 Earnings on May 3: MET, ALL & More
by Zacks Equity Research
Growing premium rates and strong retention are likely to aid insurers' Q1 results, offset by rising expenses and catastrophe losses. MET, ALL, GL, SIGI, & RDN are set to release earnings on May 3.
Zacks Industry Outlook Highlights MetLife, American International, Prudential Financial, CNO Financial and Kemper
by Zacks Equity Research
MetLife, American International, Prudential Financial, CNO Financial and Kemper have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Thriving Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, CNO and KMPR.
Will Lower Premiums Affect MetLife's (MET) Q1 Earnings?
by Zacks Equity Research
MetLife's (MET) first-quarter results are likely to reflect lower profits in Retirement & Income Solutions and MetLife Holdings businesses.
American International Group (AIG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, MetLife (MET) closed at $58.92, marking a -0.49% move from the previous day.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
MetLife (MET) closed at $60.81 in the latest trading session, marking a -1.62% move from the prior day.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
How Much Upside is Left in MetLife (MET)? Wall Street Analysts Think 34.95%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35% in MetLife (MET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Collaborates With Savi to Aid Students With Debts
by Zacks Equity Research
MetLife's (MET) Upwise partners with Savi to help students better understand the loan payment process and loan forgiveness eligibility criteria.
MET or BBSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MET vs. BBSEY: Which Stock Is the Better Value Option?
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.